Ergot and its alkaloids.
Paul L Schiff
American Journal of Pharmaceutical Education October 15, 2006 DOI: 10.5688/aj700598 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | The manuscript reviews the history, pharmacognosy, isolation and preparation, chemistry, pharmacodynamics, and pharmacotherapeutics of ergot alkaloids and their derivatives, and briefly discusses the hallucinogenic properties of lysergic acid diethylamide. An abbreviated version of this material is presented in a four-hour didactic session to third-professional-year PharmD students within a Neurology/Psychiatry module. |
Abstract
This manuscript reviews the history and pharmacognosy of ergot, and describes the isolation/preparation, chemistry, pharmacodynamics, and pharmacotherapeutics of the major ergot alkaloids and their derivatives. A brief discussion of the hallucinogenic properties of lysergic acid diethylamide is also featured. An abbreviated form of the material found in this paper is presented in a 4-hour didactic format to third-professional year PharmD students as part of their study of vascular migraine headaches, Parkinson's disease, and naturally occurring hallucinogens/hallucinogen derivatives in the modular course offering Neurology/Psychiatry.
Citations in the library
Cited by 11
- Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain. Molecular Psychiatry July 1, 2024
- Biosynthesis, total synthesis, and biological profiles of Ergot alkaloids. The Alkaloids: Chemistry and Biology 2021
- Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α-Arylation, Borrowing Hydrogen Alkylation, and C-H Insertion. The Journal of Organic Chemistry October 6, 2023
- Introduction to the chemistry and pharmacology of psychedelic drugs Australian Journal of Chemistry July 4, 2023
- Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective. Expert Review of Neurotherapeutics February 1, 2025
and 6 more in the library